In focus in HCB DOI Creative Commons
Douglas J. Taatjes, Jürgen Roth

Histochemistry and Cell Biology, Journal Year: 2024, Volume and Issue: 162(6), P. 443 - 445

Published: Aug. 31, 2024

A multimodal approach for treating post-acute infectious syndrome DOI
Charlotte Steenblock, Nicole Toepfner, Yannick P. Kok

et al.

Brain medicine :, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 7

Published: Aug. 30, 2024

Long-term complications, such as extensive fatigue and cognitive issues, are known from various infections, including SARS-CoV-2, influenza virus, or Borrelia burgdorferi . The pathology is mostly unknown differs between patients. Unfortunately, there currently no common effective treatment. In this perspective, we imply that post-acute infectious syndromes due to a variety of factors, among others diminished tissue perfusion, infiltration by viruses, inflammation, oxidative stress, not one specific biomarker can be used measure these syndromes. Thus, suggest score based on number criteria/factors should assess Consequently, probably single treatment treat group patients, multimodal regimen comprising combination pharmacotherapy, metformin naltrexone with anti-inflammatory effects, alongside physical therapies extracorporeal apheresis transcutaneous neurotherapy. This combined approach aims reduce levels enhance functions. implies reset the systems achieved for

Language: Английский

Citations

2

In focus in HCB DOI Creative Commons
Douglas J. Taatjes, Jürgen Roth

Histochemistry and Cell Biology, Journal Year: 2024, Volume and Issue: 162(6), P. 443 - 445

Published: Aug. 31, 2024

Citations

1